Fluorinated Porcine Bone-Derived Hydroxyapatite Promotes Vascularized Osteogenesis by Coordinating Human Bone Marrow Mesenchymal Stem Cell/Human Umbilical Vein Endothelial Cell Complexes
2024

Fluorinated Hydroxyapatite Enhances Bone Healing

Sample size: 30 publication 10 minutes Evidence: high

Author Information

Author(s): Wu Xiayi, Xu Chunxin, Feng Junming, Wu Shiyu, Liu Runheng, Qiao Wei, Luo Xin, Chen Shoucheng, Li Zhipeng, Chen Zhuofan, Goudy Steven L., Vozzi Giovanni

Primary Institution: Hospital of Stomatology, Sun Yat-sen University

Hypothesis

Can fluorine-modified hydroxyapatite improve vascularized osteogenesis?

Conclusion

Fluorine-modified hydroxyapatite significantly promotes early bone formation and angiogenesis.

Supporting Evidence

  • FPHA0.25 significantly upregulated VEGF mRNA and protein levels.
  • FPHA0.25 and FPHA0.50 increased PDGF-BB levels in HUVECs.
  • In vivo tests showed FPHA0.25 promoted early bone formation in rabbits.
  • Fluorine-modified hydroxyapatite maintained a porous structure similar to natural bone.
  • VEGF and PDGFR-β expression was enhanced in endothelial and mesenchymal cells.

Takeaway

This study shows that a special type of bone material with fluorine helps the body heal bones faster by improving blood flow.

Methodology

The study involved in vitro tests with human cells and in vivo tests using a rabbit model to assess bone healing.

Limitations

The study's findings may not fully replicate human conditions due to the use of a rabbit model.

Participant Demographics

New Zealand rabbits, male, aged 5-6 months.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/bioengineering11121287

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication